RKDA Q3 2025 Earnings Arcadia Biosciences Posts Surprise Profit as EPS Smashes Estimates EPM Q1 2026 Earnings Deep EPS Miss Punishes Stock as Revenue Details Remain Unreported Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses RIGL Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Stock Declines After Surprise Chemed Corp Q1 2026 Earnings EPS Surpasses Estimates as Operational Efficiency Drives Performance ATNI Q1 2026 Earnings EPS Surprise of 33693 Despite Positive Stock Movement